CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Planned sale CEO and President sold 46,409 shares at $1.83 ($84,928)
- 4 Planned sale SVP, Chief Medical Officer sold 7,144 shares at $1.83 ($13,074)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 4 Planned sale CEO and President sold 144,250 shares at $2.10 ($302,925)
- 4 Planned sale SVP, Chief Medical Officer sold 50,506 shares at $2.10 ($106,063)
- 4 Planned sale SVP, Chief Accounting Officer sold 30,202 shares at $2.10 ($63,424)
- 4 Planned sale Chief Commercial Officer sold 55,621 shares at $2.10 ($116,804)
- 4 Grant or award SVP, CFO, CBO & Treasurer acquired 194,900 shares (grant or award)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 5 of 45 · 886 filings